ENTITY

Emcure Pharmaceuticals (EMCURE IN)

32
Analysis
Health Care • India
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company that develops, manufactures, and markets a broad range of pharmaceutical products globally. The company's portfolio includes tablets, capsules, and injectables, covering therapeutic areas such as gynecology, cardiovascular, oncology, HIV antivirals, and other anti-infectives. It is headquartered in Pune, India, and was founded in 1981.
more
bullish•Kokusai Electric
•15 Jul 2024 08:48

ECM Weekly (15th July 2024) - Kokusai, Wiwynn, Kelun-Biotech, Timee, Shift Up, Sanil, Avanse

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
606 Views
Share
•12 Jul 2024 09:48

Avanse Financial Services Pre-IPO - The Negatives - Immigration Issues

Avanse Financial Services is looking to raise up to US$419m in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of...

Logo
541 Views
Share
•09 Jul 2024 14:14

Emcure Pharma Pre-IPO Trading - Strong Subscription, Will Pop

Emcure Pharmaceuticals raised around US$240m in its India IPO. Subscription rates were strong for institutional and HNI tranche.

Logo
444 Views
Share
bullish•Toyota Motor
•08 Jul 2024 08:48

ECM Weekly (8th July 2024) - Japan Cross-Shareholding, Honda, Aisin, Timee, Chenqi, Cirrus, Emcure

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
649 Views
Share
•03 Jul 2024 10:10

Emcure Pharmaceuticals Pre-IPO - Refiling Updates and Valuations

Emcure Pharmaceuticals is looking to raise around US$240m in its upcoming India IPO. In this note, we talk about valuations.

Logo
2.7k Views
Share
x